1. Is Countrywide In Trouble? With rumors swirling around its apparent liquidity problems, Countrywide Financial's stock dipped below $10 a share. The fall prompted the company to issue a statement assuring investors about its position. Are there really major problems at the mortgage giant? How much more losses can Countrywide withstand and is CEO Mozilo's job on the line? Jane Wells investigates.
 |
2. Holiday Travel Madness: Phil LeBeau is live at Chicago's O'Hare Intl. Airport taking stock of the holiday travel rush as Americans head to see their relatives for Thanksgiving. Is the stressed air system ready for the bustle or will problems confound travelers?
|
3. Can Hollywood Bounce Back? Though this year's box office is still running ahead of previous years, we've seen disappointment after disappointment. Even huge stars with huge budgets have had a rough time. This fall, studios are likely to change strategies with a move away from big budget Oscar fare and towards genre movies including horror flicks. What does it mean and what companies stand to profit? Julia Boorstin reports.
|
4. Pfizer Woes: The FDA issues an early warning about Pfizer's anti-smoking drug Chantix amid reports of suicidal thought among some patients. Mike Huckman examines this warning will likely only add to the woes of the pharmaceutical giant as it sits on its lowest stock price since January of '06.
|
5. Smoking Out Lung Cancer: Lung cancer kills more people than breast, prostate and colon cancer combined. So why is funding for research so anemic? Survivors say it's all about the stigma. Enter Laura Geller Makeup, one of the largest private cosmetics companies in the U.S, and Joan's Legacy, a lung cancer foundation. They are teaming up to deliver a unique product for an underserved market. The brand new brow brushes are a big hit with survivors and others, giving funding to the foundation and Geller's bottom line. Darby Dunn explains.
|
| |
No comments:
Post a Comment